BAX

Becton, Dickinson Delivers for Dividend Investors

Becton, Dickinson has delivered in a big way for dividend investors, with 42 consecutive years of dividend increases. Make BDX a part of your income portfolio More 

Q3 Earnings Roundup for Pharmaceutical Stocks

None of the market's major pharmaceutical stocks are in the same boat. Here's the main thing investors need to know about each. More 

47 Ways to End Earnings Season On A High Note

Earnings season may be wrapping up in the next few weeks, but the last push is going to be an important one. Get a first look with our updated portfolio ratings More 

Facebook Makes the Grade and Is Now a Buy

Yes, you read that correctly. After spending months in sell territory, Facebook has made a complete turnaround in a matter of days and is now a buy More 

Energy Amps Up the Payouts: 17 Companies Increasing Dividends

Energy XXI made one of this week's most aggressive moves among companies sweetening the dividend pot. Here's a look at EXXI and the 16 other improved payouts. More 

Baxter’s Alzheimer’s Drug Fails in Study

A drug from Baxter International aimed at reducing mental decline in Alzheimer's patients failed to show improvement compared to a placebo in a clinical trial. More 

4 Call Contenders: Healthcare

Watch these healthcare names for a continued steady climb upward--and consider profiting with call options. More